Reduced Expression of<i>CAMTA1</i>Correlates with Adverse Outcome in Neuroblastoma PatientsKai-Oliver Henrich, Frank Westermann, Matthias Fischer et al.|Clinical Cancer Research|2006Cited by 64
High <i>Skp2</i> Expression Characterizes High-Risk Neuroblastomas Independent of <i>MYCN</i> StatusFrank Westermann, Manfred Schwab, Javed Khan et al.|Clinical Cancer Research|2007Cited by 49
Integrative functional genomics identifies RINT1 as a novel GBM oncogeneSteven N. Quayle, Lynda Chin, Li Zhuang et al.|Neuro-Oncology|2012Cited by 21